Biotech News
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
investors.oculis.com2026-05-06 14:59 EST
ZUG, Switzerland, 16 March, 2026 -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Oculis), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in ophthalmology and neuro-ophthalmology, today announced the presentation of the ACUITY Phase